TELA Bio, Inc.
TELA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $21 | $20 | $19 | $18 |
| % Growth | 2.4% | 9.1% | 4.9% | – |
| Cost of Goods Sold | $7 | $6 | $6 | $6 |
| Gross Profit | $14 | $14 | $13 | $11 |
| % Margin | 67.5% | 69.8% | 67.6% | 63.6% |
| R&D Expenses | $2 | $2 | $3 | $2 |
| G&A Expenses | $4 | $4 | $4 | $4 |
| SG&A Expenses | $19 | $21 | $20 | $18 |
| Sales & Mktg Exp. | $15 | $17 | $17 | $14 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $22 | $23 | $23 | $20 |
| Operating Income | -$8 | -$9 | -$10 | -$8 |
| % Margin | -36.5% | -45% | -56.5% | -47.3% |
| Other Income/Exp. Net | -$1 | -$1 | -$1 | -$1 |
| Pre-Tax Income | -$9 | -$10 | -$11 | -$9 |
| Tax Expense | $0 | $0 | $0 | -$0 |
| Net Income | -$9 | -$10 | -$11 | -$9 |
| % Margin | -41.6% | -49.1% | -60.8% | -52.2% |
| EPS | -0.19 | -0.22 | -0.25 | -0.23 |
| % Growth | 13.6% | 12% | -8.7% | – |
| EPS Diluted | -0.19 | -0.22 | -0.25 | -0.23 |
| Weighted Avg Shares Out | 45 | 45 | 45 | 40 |
| Weighted Avg Shares Out Dil | 45 | 45 | 45 | 40 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1 | $1 | $1 | $1 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$7 | -$8 | -$10 | -$8 |
| % Margin | -34.6% | -41.7% | -52.5% | -44.2% |